Search

everythinglearnresearchcommunity

for

Search:↓

Father's finasteride use may affect son's fertility and testicular function.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Low-level laser therapy may improve hair regrowth and thickness for androgenetic alopecia, but more research is needed.

BTA safely and effectively treats hair loss, and works better with FNS.

Use finasteride over dutasteride for hair loss; consider topical treatments and weigh risks.

3D cell-derived matrices improve tissue regeneration and disease modeling.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

3D-printed mesoporous scaffolds show promise for personalized drug delivery with controlled release.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

AI is revolutionizing healthcare by improving diagnosis, treatment, and monitoring, but still needs close supervision.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Bioprinting could improve wound healing but needs more development to match real skin.

Innovative methods are reducing animal testing and improving biomedical research.

The conclusion is that accurately replicating the complexity of the extracellular matrix in the lab is crucial for creating realistic human tissue models.

Creating fully functional artificial skin for chronic wounds is still very challenging.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.

Botulinum Toxin A may help with hair growth and has some side effects; more research is needed.

Exosomes could be a promising way to help repair skin and treat skin disorders.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.